Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7

Cancer Research

Volumn 67, Issue 17, 2007, Pages 7996-8001

  Boonstra, Jurjen J ^a,b   Van Der Velden, Albertina W ^b   Beerens, Erwin C W ^b   Van Marion, Ronald ^b   Morita Fujimura, Yuiko ^c   Matsui, Yasuhisa ^c   Nishihira, Tetsuro ^d   Tselepis, Chris ^e   Hainaut, Pierre ^f   Lowe, Anson W ^g   Beverloo, Berna H ^a   Van Dekken, Herman ^b   Tilanus, Hugo W ^a   Dinjens, Winand N M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^c TOHOKU UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL CULTURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FRANCE; GENOTYPE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; LABORATORY TEST; MUTATION; NETHERLANDS; PRIORITY JOURNAL; SHORT TANDEM REPEAT; UNITED KINGDOM; UNITED STATES; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; DNA MUTATIONAL ANALYSIS; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC HETEROGENEITY; GENOTYPE; HUMANS; MICE; MICE, NUDE; TISSUE ARRAY ANALYSIS; TRANSPLANTATION, HETEROLOGOUS;

EID: 34548546555     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-2064     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol 1999;26:2-8.
3. Masters JR. Human cancer cell lines: fact and fantasy. Nat Rev Mol Cell Biol 2000;1:233-6.
4. Masters JR, Thomson JA, Daly-Burns B, et al. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci U S A 2001;98:8012-7.
5. Chatterjee R. Cases of mistaken identity. Science 2007;315:928-31.
6. Parson W, Kirchebner R, Muhlmann R, et al. Cancer cell line identification by short tandem repeat profiling: power and limitations. FASEB J 2005;19:434-6.
7. van Helden PD, Wiid IJ, Albrecht CF, Theron E, Thornley AL, Hoal-van Helden EG. Cross-contamination of human esophageal squamous carcinoma cell lines detected by DNA fingerprint analysis. Cancer Res 1988;48:5660-2.
8. Nishihira T, Kasai M, Mori S, et al. Characteristics of two cell lines (TE-1 and TE-2) derived from human squamous cell carcinoma of the esophagus. Gann 1979;70:575-84.
9. Kuriya Y, Kitamura M, Akaishi T, et al. A new cell line (TE-3) derived from human squamous cell carcinoma of the esophagus. Tohoku J Exp Med 1983;139:377-87.
10. Nishihira T, Hashimoto Y, Katayama M, Mori S, Kuroki T. Molecular and cellular features of esophageal cancer cells. J Cancer Res Clin Oncol 1993;119:441-9.
11. Hollstein MC, Metcalf RA, Welsh JA, Montesano R, Harris CC. Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci U S A 1990;87:9958-61.
12. Barnas C, Martel-Planche G, Furukawa Y, Hollstein M, Montesano R, Hainaut P. Inactivation of the p53 protein in cell lines derived from human esophageal cancers. Int J Cancer 1997;71:79-87.
13. Benzeno S, Lu F, Guo M, et al. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene 2006;25:6291-303.
14. Nakajima M, Fukuchi M, Miyazaki T, Masuda N, Kato H, Kuwano H. Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma. Br J Cancer 2003;88:1734-9.
15. Knijnenburg J, Szuhai K, Giltay J, et al. Insights from genomic microarrays into structural chromosome rearrangements. Am J Med Genet 2005;132:36-40.
16. van Dekken H, Wink JC, Vissers KJ, et al. Genomic analysis of early adenocarcinoma of the esophagus or gastroesophageal junction: tumor progression is associated with alteration of 1q and 8p sequences. Genes Chromosomes Cancer 2006;45:516-25.
17. Stacey GN, Bolton BJ, Doyle A. DNA fingerprinting transforms the art of cell authentication. Nature 1992;357:261-2.
18. Kan T, Shimada Y, Sato F, et al. Gene expression profiling in human esophageal cancers using cDNA microarray. Biochem Biophys Res Commun 2001;286:792-801.
19. Hao Y, Triadafilopoulos G, Sahbaie P, Young HS, Omary MB, Lowe AW. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology 2006;131:925-33.
20. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R. Expression and up-regulation of retinoic acid receptor-β is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res 1999;59:2477-83.
21. Takashima T, Fujiwara Y, Higuchi K, et al. PPAR-γ ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. Int J Oncol 2001;19:465-71.
22. Fujii D, Yoshida K, Tanabe K, Hihara J, Toge T. The ligands of peroxisome proliferator-activated receptor (PPAR) γ inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest. Anticancer Res 2004;24:1409-16.